Skip to main content
padlock icon - secure page this page is secure

Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense‐mediated decay

Buy Article:

$59.00 + tax (Refund Policy)

Summary

Objectives  Growth hormone insensitivity syndrome (GHIS) is characterized by extreme short stature and resistance to the actions of growth hormone (GH). The heterogeneity ranges from the most severe form, known as Laron syndrome, to less severe phenotypes like idiopathic short stature and partial GH insensitivity. Here, we aimed to identify and characterize the molecular cause of severe short stature in a patient with resistance to GH treatment.

Patient  We describe a male patient born small for gestational age [38 weeks gestation, length 38·5 cm; −7·8 standard deviation score (SDS), weight 1350 g; −4·84 SDS]. At the age of 7 years (109·7 cm; −2·89 SD), he received GH treatment (1 mg/m2/day) for 1 year without any increase in height SDS, IGF‐I or IGFBP‐3 levels. Double‐GH‐dose treatment for another year did not result in any improvement in growth factor level either. The patient does not have the typical Laron craniofacial and somatic features.

Results  Analysis of GHR showed a heterozygous nonsense mutation (c.703C>T; p.Arg217X). Extensive mutation screening as well as copy number variation analysis of other candidate genes in the GH‐IGF‐I axis excluded any additional genetic defects. Analysis of the patient’s fibroblasts showed that growth hormone receptor (GHR) messenger ribonucleic acid (mRNA) expressed from the mutant allele was degraded by a mechanism called nonsense‐mediated mRNA decay (NMD).

Conclusions  GHIS in this patient is because of a heterozygous nonsense mutation in GHR. Our study is the first to demonstrate that NMD is involved in the phenotypic variability of GHIS caused by GHR mutations.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Affiliations: Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands

Publication date: May 1, 2012

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more